P3 Health Partners Inc.
PIIINasdaqCIK 1832511HealthcareFiscal year ends Dec 31
Reports and events: 137 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1120:28 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws | 0001832511-26-000036 |
| 2026-08-1220:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-094924 |
| 2026-08-1020:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001832511-26-000034 |
| 2026-08-1020:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000032 |
| 2026-07-0621:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000029 |
| 2026-06-1021:54 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001832511-26-000027 |
| 2026-05-2620:06 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001832511-26-000026 |
| 2026-05-1520:58 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001832511-26-000024 |
| 2026-05-1420:29 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001832511-26-000022 |
| 2026-05-1420:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000021 |
| 2026-04-3020:16 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001140361-26-018240 |
| 2026-04-2821:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws | 0001832511-26-000018 |
| 2026-03-2620:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001832511-26-000011 |
| 2026-03-2620:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-26-000010 |
| 2026-03-2521:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000006 |
| 2026-02-1721:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-26-000005 |
| 2025-11-2818:29 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001832511-25-000028 |
| 2025-11-1423:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001832511-25-000025 |
| 2025-11-1423:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-25-000024 |
| 2025-11-1423:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-25-000023 |
| 2025-08-2920:17 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001832511-25-000015 |
| 2025-08-1420:56 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001832511-25-000013 |
| 2025-08-1420:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001832511-25-000010 |
| 2025-07-0914:40 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-034559 |
| 2025-06-1022:11 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-030297 |
| 2025-06-0620:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-052103 |
| 2025-06-0321:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-029146 |
| 2025-05-1520:57 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-026021 |
| 2025-05-1520:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-025928 |
| 2025-04-2920:27 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0001140361-25-016302 |
| 2025-04-1700:09 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-25-018083 |
| 2025-04-0420:59 ET | 8-K | 8.01 Other events | 0001628280-25-016833 |
| 2025-04-0323:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-016337 |
| 2025-03-2801:02 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-015305 |
| 2025-03-2720:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-015165 |
| 2025-03-0322:04 ET | DEF 14A | Proxy statementPeriod 2025-03-31 | 0001140361-25-006787 |
| 2025-02-1812:48 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-25-005930 |
| 2025-02-1313:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-005308 |
| 2025-01-3100:08 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-009005 |
| 2024-12-1721:25 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-24-051677 |
| 2024-11-1221:26 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047186 |
| 2024-11-1221:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047123 |
| 2024-11-0822:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-095994 |
| 2024-08-2920:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-038802 |
| 2024-08-0720:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035649 |
| 2024-08-0720:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035600 |
| 2024-06-2620:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-169102 |
| 2024-06-0720:53 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-027325 |
| 2024-05-2420:21 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-065141 |
| 2024-05-2312:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001104659-24-064559 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.